MannKind (MNKD) Sees Ending FY14 with $160M+ Cash
Tweet
Share
E-mailGet Alerts MNKD Hot Sheet
Price: $4.19 --0%
EPS Growth %: +175.0%
Financial Fact:
Loss from operations: 118.23M
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: +175.0%
Financial Fact:
Loss from operations: 118.23M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
MannKind (NASDAQ: MNKD) sees ending 2014 with over $160 million in cash and expects declining cash burn in 2015.
The company also sees a Q115 release of Afrezza, according to a presentation at the JPMorgan Healthcare Conference.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb (BMY) stock slips despite earnings beat
- The Shyft Group (SHYF) Tops Q1 EPS by 10c ; Offers Guidance
- Altria (MO) delivers in-line earnings, revenue in Q1; shares slightly up
Create E-mail Alert Related Categories
Guidance, Trader TalkRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
